Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

365 ARTÍCULOS , VIENDO DEL 106 AL 120

[Development of anti-Alzheimer's disease drug based on beta-amyloid hypothesis]

Sugimoto H.

Yakugaku Zasshi. 2010 Apr;130(4):521-6. doi: 10.1248/yakushi.130.521.

Vitamin E forms in Alzheimer's disease: a review of controversial and clinical experiences

Usoro OB, Mousa SA.

Crit Rev Food Sci Nutr. 2010 May;50(5):414-9. doi: 10.1080/10408390802304222.

Safety and changes in plasma and cerebrospinal fluid amyloid beta after a single administration of an amyloid beta monoclonal antibody in subjects with Alzheimer disease

Siemers ER, Friedrich S, Dean RA, Gonzales CR, Farlow MR, Paul SM, Demattos RB.

Clin Neuropharmacol. 2010 Mar-Apr;33(2):67-73. doi: 10.1097/WNF.0b013e3181cb577a.

Immune-inflammatory responses and oxidative stress in Alzheimer's disease: therapeutic implications

Di Bona D, Scapagnini G, Candore G, Castiglia L, Colonna-Romano G, Duro G, Nuzzo D, Iemolo F, Lio D, Pellicanò M, Scafidi V, Caruso C, Vasto S.

Curr Pharm Des. 2010;16(6):684-91. doi: 10.2174/138161210790883769.

Simple choline esters as potential anti-Alzheimer agents

Alcaro S, Arcone R, Costa G, De Vita D, Iannone M, Ortuso F, Procopio A, Pasceri R, Rotiroti D, Scipione L.

Curr Pharm Des. 2010;16(6):692-7. doi: 10.2174/138161210790883796.

Immunotherapy for Alzheimer's disease

Solomon B, Frenkel D.

Neuropharmacology. 2010 Sep-Oct;59(4-5):303-9. doi: 10.1016/j.neuropharm.2010.04.004. Epub 2010 Apr 11.

Proteases and proteolysis in Alzheimer disease: a multifactorial view on the disease process

De Strooper B.

Physiol Rev. 2010 Apr;90(2):465-94. doi: 10.1152/physrev.00023.2009.

Oxidative stress in Alzheimer disease: a possibility for prevention

Bonda DJ, Wang X, Perry G, Nunomura A, Tabaton M, Zhu X, Smith MA.

Neuropharmacology. 2010 Sep-Oct;59(4-5):290-4. doi: 10.1016/j.neuropharm.2010.04.005. Epub 2010 Apr 13.

Aneuploidy and adult neurogenesis in Alzheimer's disease: therapeutic strategies

Taupin P.

Drug Discov Today. 2010 Dec;15(23-24):983-4. doi: 10.1016/j.drudis.2010.04.001. Epub 2010 Apr 13.

L-methylfolate, methylcobalamin, and N-acetylcysteine in the treatment of Alzheimer's disease-related cognitive decline

McCaddon A, Hudson PR.

CNS Spectr. 2010 Jan;15(1 Suppl 1):2-5; discussion 6. doi: 10.1017/s1092852900027589.

Anticholinesterase duration in the Australian veteran population

Gadzhanova S, Roughead L, Mackson J.

Aust N Z J Psychiatry. 2010 May;44(5):469-74. doi: 10.3109/00048670903555104.

ACAT inhibition and amyloid beta reduction

Bhattacharyya R, Kovacs DM.

Biochim Biophys Acta. 2010 Aug;1801(8):960-5. doi: 10.1016/j.bbalip.2010.04.003. Epub 2010 Apr 14.

Alzheimer's disease drug discovery: Abeta and beyond

Shineman DW, Fillit HM.

Curr Alzheimer Res. 2010 May;7(3):188-9. doi: 10.2174/156720510791050939.

REVIEW: Curcumin and Alzheimer's disease

Hamaguchi T, Ono K, Yamada M.

CNS Neurosci Ther. 2010 Oct;16(5):285-97. doi: 10.1111/j.1755-5949.2010.00147.x.

Rivastigmine-induced REM sleep behavior disorder (RBD) in a 88-year-old man with Alzheimer's disease

Yeh SB, Yeh PY, Schenck CH.

J Clin Sleep Med. 2010 Apr 15;6(2):192-5.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias